Three decades ago, a scientist at the University of Texas named Bruce Beutler asked the U.S. government to grant him a patent for a new invention. Beutler, who would later win the Nobel Prize for his ...
The Health Resources and Services Administration is again pushing to include rebates in the drug discount program after a ...
Regulators say the telehealth company illegally shared patients’ health data with advertisers and misled its customers. Hims ...
The expansion will create 400 jobs dedicated to making GLP-1 injectables across Resilience’s contract manufacturing ...
Ziltivekimab's failure in a key trial spurred share sell-offs for Novo and other biotechs, as it suggested trouble for ...
The startups are part of a surge of young companies equipped with advanced drug prospects and quickly pivoting to the public ...
The positive vote came despite persistent concerns from FDA scientists and positions the company to bounce back from two ...
Vertex Pharmaceuticals has struck a deal with AbCellera to develop new types of T-cell engagers for autoimmune diseases and, ...
The RNA-focused biotech shed 30% of its market value — or close to $12 billion — amid growing investor concerns about its ...
The pharma hasn’t yet revealed what kind of job cuts might be involved in the plan, which will help it absorb the coming loss ...
Shares fell more than 66% Monday morning, which analysts suspect is due to investors seeing the data as not competitive with ...
Capricor shares lost much of their value ahead of a high-stakes advisory committee meeting. Elsewhere, Ying Huang’s resignation extended a stock slide for Legend and AstraZeneca disclosed more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results